Innovation Grant Awarded for Qu Biologics Project with University of Ottawa Scientist
04 avr. 2017 15h15 HE
|
Qu Biologics
VANCOUVER, British Columbia, April 04, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...